Off-pump cardiac surgery abolishes complement activation

Perfusion

Volumn 22, Issue 4, 2007, Pages 251-256

  Hoel, Tom N ^a   Videm, Vibeke ^a   Mollnes, Tom E ^b   Saatvedt, Kjell ^a   Brosstad, Frank ^c   Fiane, Arnt E ^a   Fosse, Erik ^c   Svennevig, Jan L ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; COMPLEMENT; COMPLEMENT COMPONENT C3B; MYELOPEROXIDASE; PROTHROMBIN;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; ELECTIVE SURGERY; HEART LUNG MACHINE; HUMAN; HUMAN CELL; INFLAMMATION; INTRAOPERATIVE PERIOD; LEUKOCYTE ACTIVATION; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; STABLE ANGINA PECTORIS; THROMBOCYTE ACTIVATION;

BLOOD COAGULATION; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; EXTRACORPOREAL CIRCULATION; HEART DISEASES; HEART-LUNG MACHINE; HUMANS; NEUTROPHIL ACTIVATION; PLATELET ACTIVATION;

EID: 36749007188     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659107084142     Document Type: Article

References (24)

1. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983 Dec; 86(6): 845-57.
2. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981 Feb 26; 304(9): 497-503.
3. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993; 7(11): 563-73.
4. Despotis GJ, Avidan MS, Hogue CW, Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001 Nov; 72(5): S1821-S1831.
5. Videm V, Mollnes TE, Bergh K, Fosse E, Mohr B, Hagve TA et al. Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo. J Thorac Cardiovasc Surg 1999 Apr; 117(4): 803-9.
6. Bucerius J, Gummert JF, Walther T et al. Impact of off-pump coronary bypass grafting on the prevalence of adverse perioperative outcome in women undergoing coronary artery bypass grafting surgery. Ann Thorac Surg 2005 Mar; 79(3): 807-12.
7. Gobran SR, Goldman S, Ferdinand F et al. Outcomes after usage of a quality initiative program for off-pump coronary artery bypass surgery: a comparison with on-pump surgery. Ann Thorac Surg 2004 Dec; 78(6): 2015-21.
8. Ascione R, Caputo M, Angelini GD. Off-pump coronary artery bypass grafting: not a flash in the pan. Ann Thorac Surg 2003 Jan; 75(1): 306-13.
9. Gu MD P, Mariani MD P, van Oeveren PhD W, Grandjean MD P, Boonstra MD P. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 1998 Feb; 65(2): 420-4.
10. Matata BM, Sosnowski AW, Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 2000 Mar; 69(3): 785-91.
11. Murphy GJ, Angelini GD. Side effects of cardiopulmonary bypass: what is the reality? J Card Surg 2004 Nov; 19(6): 481-8.
12. Fosse E, Mollnes TE, Ingvaldsen B. Complement activation during major operations with or without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987 Jun; 93(6): 860-6.
13. Mollnes TE, Lea T, Harboe M. Detection and quantification of the terminal C5b-9 complex of human complement by a sensitive enzyme-linked immunosorbent assay. Scand J Immunol 1984 Aug; 20(2): 157-66.
14. Garred P, Mollnes TE, Lea T. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988 Mar; 27(3): 329-35.
15. Mollnes TE, Lea T, Froland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985 Aug; 22(2): 197-202.
16. Videm V, Nilsson L, Venge P, Svennevig JL. Reduced granulocyte activation with a heparin-coated device in an in vitro model of cardiopulmonary bypass. Artif Organs 1991 Apr; 15(2): 90-5.
17. Mollnes TE, Videm V, Christiansen D, Bergseth G, Riesenfeld J, Hovig T. Platelet compatibility of an - artificial surface modified with functionally active heparin. Thromb Haemost 1999 Sep; 82(3): 1132-6.
18. Altman DG. Practical statistics for medical research. Chapman & Hall, London 1996, pp. 326-31.
19. Sellke FW, DiMaio JM, Caplan LR et al. Comparing on-pump and off-pump coronary artery bypass grafting: numerous studies but few conclusions: a scientific statement from the American Heart Association council on cardiovascular surgery and anesthesia in collaboration with the interdisciplinary working group on quality of care and outcomes research. Circulation 2005 May 31; 111(21): 2858-64.
20. Mollnes TE, Videm V, Riesenfeld J et al. Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials. Clin Exp Immunol 1991 Oct; 86 Suppl (1): 21-6.
21. Wagner JL, Hugli TE. Radioimmunoassay for anaphylatoxins: a sensitive method for determining complement activation products in biological fluids. Anal Biochem 1984 Jan; 136(1): 75-88.
22. Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992 Apr; 103(4): 806-13.
23. Mariani MA, Gu YJ, Boonstra PW, Grandjean JG, van Oeveren W, Ebels T. Procoagulant activity after off-pump coronary operation: is the current anticoagulation adequate? Ann Thorac Surg 1999 May 1; 67(5): 1370-75.
24. Englberger L, Immer FF, Eckstein FS, Berdat PA, Haeberli A, Carrel TP. Off-pump coronary artery bypass operation does not increase procoagulant and fibrinolytic activity: preliminary results. Ann Thorac Surg 2004 May; 77(5): 1560-66.